Live Analyst Rating Changes 28882 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Ivan Bokhmat
BARC

Ivan Bokhmat

Barclays
Wall Street Analyst
★★★☆☆
#1085
on 13Foresight · ranked by our own returns
60%
Success Rate
+5.3%
Average Return
18 of 30 calls profitable · -2.1% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 60% of Ivan Bokhmat's ratings turned a profit when each position was held for 1 year — averaging +5.3% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

39 Buy 23 Hold 28 Sell
Ivan's Stock Coverage 19 ratings · 2026-08-31
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
GB:PRU
Prudential
 Aug 27, 2026 BUY Strong Buy
+750.0% avg upside
23 analysts
$1400.00
37.47% Upside
 · ·
GB:AV
Aviva plc
 Aug 17, 2026 HOLD Buy
-8.6% avg upside
17 analysts
$656.00
10.26% Downside
 -2.0% ·
GB:HSX
Hiscox
 Aug 06, 2026 BUY Strong Buy
+276.0% avg upside
15 analysts
$1820.00
1.23% Downside
 +0.3% ·
GB:SBRE
Sabre Insurance Group plc
 Aug 04, 2026 BUY Buy
+10.9% avg upside
7 analysts
$194.00
13.37% Upside
 -2.4% ·
GB:LRE
Lancashire Holdings
 Jul 30, 2026 HOLD Buy
+541.3% avg upside
12 analysts
$610.00
1.06% Downside
 +2.1% ·
GB:CRE
Conduit Holdings Ltd
 Jul 30, 2026 SELL Buy
+10.7% avg upside
6 analysts
$410.00
9.62% Downside
 -4.0% ·
DE:MUV2
Munich Reinsurance
 Jul 22, 2026 BUY Buy
-7.7% avg upside
17 analysts
$576.00
11.24% Upside
 +1.6% ·
CH:SREN
Swiss Re AG
 Jul 22, 2026 SELL Hold
-13.6% avg upside
15 analysts
$116.00
17.72% Downside
 -5.7% ·
FR:SCR
SCOR
 Jul 06, 2026 HOLD Buy
-1.4% avg upside
12 analysts
$30.70
9.21% Downside
 +5.5% ·
DE:HNR1
Hannover Rueck
 May 26, 2026 SELL Buy
+3.4% avg upside
16 analysts
$246.00
4.45% Downside
 -6.6% ·
GB:ADM
Admiral
 Jan 29, 2026 BUY Buy
-15.6% avg upside
14 analysts
$3264.00
18.90% Downside
 +49.1% ·
GB:BEZ
Beazley
 Nov 25, 2025 BUY Strong Buy
+150.7% avg upside
14 analysts
$1020.00
21.44% Downside
 +66.0% ·
ES:MAP
Mapfre, SA
 Apr 11, 2023 SELL Hold
-31.1% avg upside
4 analysts
$1.75
61.04% Downside
 -27.5% ·
DE:ALV
Allianz
 Jun 30, 2022 HOLD Buy
-17.4% avg upside
23 analysts
 — +23.5% ·
CH:ZURN
Zurich Insurance Group
 Jun 30, 2022 BUY Hold
-1.7% avg upside
16 analysts
 — +6.8% ·
FR:CS
AXA SA
 Jun 30, 2022 BUY Strong Buy
+6.1% avg upside
19 analysts
 — +32.2% ·
IT:G
Assicurazioni Generali S.p.A.
 Jun 30, 2022 SELL Hold
-16.2% avg upside
16 analysts
 — -27.4% ·
NL:NN
NN Group N.V.
 Feb 18, 2019 SELL Buy
-12.9% avg upside
13 analysts
$110.50
41.69% Upside
 -2.6% ·
SSREY
Swiss Re
 Dec 13, 2018 BUY Strong Buy
+200.3% avg upside
4 analysts
$125.81
188.53% Upside
 +28.8% ·
🔒 14 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Ivan Bokhmat — Frequently Asked Questions
How accurate are Ivan Bokhmat's stock ratings?
Based on the calls 13Foresight could measure, about 60% of Ivan's ratings were profitable over a one-year hold, with an average return of +5.3% per rating, or -2.1% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Ivan ranked on 13Foresight?
Ivan Bokhmat is currently ranked #1085 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Ivan cover?
Ivan most recently has ratings on GB:PRU, GB:AV, GB:HSX, GB:SBRE, GB:LRE, GB:CRE, DE:MUV2, CH:SREN, FR:SCR, DE:HNR1, GB:ADM, GB:BEZ and 7 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.